logo
New coating forms strong, lasting rust barrier for iron with 99.6% efficiency

New coating forms strong, lasting rust barrier for iron with 99.6% efficiency

Yahoo12-06-2025
A new dual-layer coating has been developed that offers 99.6% protection against iron corrosion.
Iron gives modern infrastructure strength, from soaring skyscrapers to vital bridges.
However, a persistent, unseen foe is always at play, eroding its strength: rust.
Iron corrodes when exposed to air and moisture, causing structural damage, safety risks, and extremely high maintenance costs. Current protective solutions are often inadequate, providing only temporary defense against this persistent problem.
The researchers from Hebrew University of Jerusalem focused on developing a strong, durable shield for iron that would protect it for decades.
"This discovery offers a major leap forward in protecting iron from corrosion," said Professor Elad Gross, who led the development.
"By using a specially designed primer, we created a coating that is not only highly effective but also long-lasting. This could reduce maintenance costs, extend the lifespan of iron-based materials, and provide industries with a much more reliable solution," Gross added.
Metals naturally corrode over time, but the rate for each differs. Iron is known to rust quickly, but gold and silver can resist deterioration for decades or centuries.
A study conducted some time ago indicated that the global expense of corrosion amounted to a whopping US$2.5 trillion. Though protective coatings are available, many frequently break down, failing to provide lasting protection.
This development features a dual-layer coating: a thin molecular primer paired with a tough polymer layer. Overall, it creates a durable, long-lasting barrier against rust.
The coating development follows a two-pronged approach.
First, an ultra-thin molecular primer made of N-Heterocyclic Carbene (NHC) forms an incredibly tight, chemical bond directly with the iron surface.
Acting as the ultimate bond, this primer ensures the tough polymer layer adheres strongly, creating an unbreakable protective barrier.
The coating remains intact, even in the harshest conditions, like excessive and prolonged exposure to highly corrosive saltwater.
Under rigorous testing, the dual-layer coating proved remarkably effective at reducing corrosion.
Moreover, thanks to this strong connection, the coating is tougher than standard options that tend to wear down or flake off.
The coating, if widely adopted, promises to increase the durability of iron-based products in construction, transportation, and manufacturing.
It could reduce maintenance costs for bridges, pipelines, and ships.
'By reducing the need for frequent repairs and replacements, this coating could also contribute to more sustainable and cost-effective material use,' the researchers noted.
A recent report indicates that the 'corrosion inhibitor market' is valued at $8.93 billion and is predicted to grow by 3.6% annually between 2025 and 2030.
Earlier, researchers from the Indian Institute of Technology (IIT) - Bombay developed a novel technique to measure the degradation rate of protective coatings on iron.
Reportedly, the team used the combination of hydrogen permeation-based potentiometry (HPP) and electrochemical impedance spectroscopy (EIS). This technique could lead to precise measurement of degradation right where the organic coating meets the metal.
The new findings were published in the journal Angewandte Chemie International Edition.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SpaceX delivers new crew to orbiting station in just 15 hours
SpaceX delivers new crew to orbiting station in just 15 hours

Yahoo

time2 hours ago

  • Yahoo

SpaceX delivers new crew to orbiting station in just 15 hours

SpaceX delivered a fresh crew to the International Space Station on Saturday, making the trip in a quick 15 hours. The four US, Russian and Japanese astronauts pulled up in their SpaceX capsule after launching from Nasa's Kennedy Space Centre. They will spend at least six months at the orbiting lab, swapping places with colleagues who have been up there since March. SpaceX will bring those four back as early as Wednesday. Moving in are Nasa's Zena Cardman and Mike Fincke, Japan's Kimiya Yui and Russia's Oleg Platonov – each of whom had been originally assigned to other missions. 'Hello, space station,' Mr Fincke radioed as soon as the capsule docked high above the South Pacific. Ms Cardman and another astronaut were pulled from a SpaceX flight last year to make room for Nasa's two stuck astronauts, Boeing Starliner test pilots Butch Wilmore and Suni Williams, whose space station stay went from one week to more than nine months. Mr Fincke and Mr Yui had been training for the next Starliner mission. But with Starliner grounded by thruster and other problems until 2026, the two switched to SpaceX. Mr Platonov was bumped from the Soyuz launch line-up a couple of years ago because of an undisclosed illness. Their arrival temporarily puts the space station population at 11. The astronauts greeting them had cold drinks and hot food waiting for them. While their taxi flight was speedy by US standards, the Russians hold the record for the fastest trip to the space station – a lightning-fast three hours.

Astria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE Patients
Astria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE Patients

Yahoo

time2 hours ago

  • Yahoo

Astria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE Patients

Astria Therapeutics Inc. (NASDAQ:ATXS) is one of the stocks under $10 to buy now. Earlier on June 13, Astria Therapeutics announced positive initial results from the ALPHA-SOLAR long-term open-label trial of navenibart (STAR-0215) in hereditary angioedema/HAE patients. These findings were presented at the European Academy of Allergy and Clinical Immunology/EAACI Annual Congress. The trial showed an overall reduction in the monthly HAE attack rate, with a 92% mean and 97% median reduction. These results support the potential for every three-month and every six-month dosing regimens for navenibart, as well as its favorable safety and tolerability profile. These initial results from ALPHA-SOLAR are consistent with the 'best-in-class' profile observed in the earlier ALPHA-STAR Phase 1b/2 trial. A closeup of pills in a pharmacy, representing the high quality medications of the company. The ALPHA-SOLAR trial is a long-term, open-label study designed to assess the safety and efficacy of navenibart in adults with HAE Type 1 or 2. All 16 target enrollment participants from the Phase 1b/2 ALPHA-STAR trial opted to enroll in ALPHA-SOLAR. Patients from ALPHA-STAR Cohorts 1 and 2 joined Arm A, while Cohort 3 patients joined Arm B. Astria Therapeutics Inc. (NASDAQ:ATXS) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for allergic and immunological diseases in the US. While we acknowledge the potential of ATXS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store